These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25639352)

  • 1. Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.
    Fang F; Sun S; Wang L; Guan JL; Giovannini M; Zhu Y; Liu F
    J Bone Miner Res; 2015 Jul; 30(7):1195-205. PubMed ID: 25639352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of craniofacial bone lesion of tuberous sclerosis complex.
    Fang F; Wei X; Hu M; Liu F
    Musculoskelet Regen; 2015; 1(1):. PubMed ID: 26052552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mouse model of tuberous sclerosis complex (TSC): eye-specific Tsc1-ablation disrupts visual-pathway development.
    Jones I; Hägglund AC; Törnqvist G; Nord C; Ahlgren U; Carlsson L
    Dis Model Mech; 2015 Dec; 8(12):1517-29. PubMed ID: 26449264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations.
    Aksoylu IS; Martin P; Robert F; Szkop KJ; Redmond NE; Bhattacharyya S; Wang J; Chen S; Beauchamp RL; Nobeli I; Pelletier J; Larsson O; Ramesh V
    Mol Autism; 2023 Oct; 14(1):39. PubMed ID: 37880800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling.
    Martin P; Wagh V; Reis SA; Erdin S; Beauchamp RL; Shaikh G; Talkowski M; Thiele E; Sheridan SD; Haggarty SJ; Ramesh V
    Mol Autism; 2020; 11(1):2. PubMed ID: 31921404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models.
    Magri L; Cominelli M; Cambiaghi M; Cursi M; Leocani L; Minicucci F; Poliani PL; Galli R
    Dis Model Mech; 2013 Sep; 6(5):1185-97. PubMed ID: 23744272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Tsc1 accelerates malignant gliomagenesis when combined with oncogenic signals.
    Yamada D; Hoshii T; Tanaka S; Hegazy AM; Kobayashi M; Tadokoro Y; Ohta K; Ueno M; Ali MA; Hirao A
    J Biochem; 2014 Apr; 155(4):227-33. PubMed ID: 24368778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.
    Carson RP; Van Nielen DL; Winzenburger PA; Ess KC
    Neurobiol Dis; 2012 Jan; 45(1):369-80. PubMed ID: 21907282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123).
    Crowell B; Lee GH; Nikolaeva I; Dal Pozzo V; D'Arcangelo G
    eNeuro; 2015; 2(6):. PubMed ID: 26693177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.
    Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP
    Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.
    Magri L; Cambiaghi M; Cominelli M; Alfaro-Cervello C; Cursi M; Pala M; Bulfone A; Garcìa-Verdugo JM; Leocani L; Minicucci F; Poliani PL; Galli R
    Cell Stem Cell; 2011 Nov; 9(5):447-62. PubMed ID: 22056141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
    Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
    Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1.
    Zhou J; Brugarolas J; Parada LF
    Hum Mol Genet; 2009 Nov; 18(22):4428-41. PubMed ID: 19692352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTORC1-mediated downregulation of COX2 restrains tumor growth caused by TSC2 deficiency.
    Li H; Jin F; Jiang K; Ji S; Wang L; Ni Z; Chen X; Hu Z; Zhang H; Liu Y; Qin Y; Zha X
    Oncotarget; 2016 May; 7(19):28435-47. PubMed ID: 27078846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner.
    Bilanges B; Argonza-Barrett R; Kolesnichenko M; Skinner C; Nair M; Chen M; Stokoe D
    Mol Cell Biol; 2007 Aug; 27(16):5746-64. PubMed ID: 17562867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice.
    Liu W; Wang Z; Yang J; Wang Y; Li K; Huang B; Yan B; Wang T; Li M; Zou Z; Yang J; Xiao G; Cui ZK; Liu A; Bai X
    Open Biol; 2019 May; 9(5):180262. PubMed ID: 31088250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex.
    Cambiaghi M; Cursi M; Magri L; Castoldi V; Comi G; Minicucci F; Galli R; Leocani L
    Neuropharmacology; 2013 Apr; 67():1-7. PubMed ID: 23159330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerotic bone lesions in tuberous sclerosis complex: A genotype-phenotype study.
    Boronat S; Barber I; Thiele EA
    Am J Med Genet A; 2017 Jul; 173(7):1891-1895. PubMed ID: 28488386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing
    Klover PJ; Thangapazham RL; Kato J; Wang JA; Anderson SA; Hoffmann V; Steagall WK; Li S; McCart E; Nathan N; Bernstock JD; Wilkerson MD; Dalgard CL; Moss J; Darling TN
    Elife; 2017 Jul; 6():. PubMed ID: 28695825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.